SLC6A3 and Parkinson disease: Here, we implemented this encoding and retrieval methodology to investigate whether SLC6A3 gene polymorphisms impact cognition and responses to dopaminergic therapy in PD, and particularly whether these effects are dissimilar for functions mediated by VTA-innervated brain regions vs. DS.